NO950387L - Nye tiazin- eller tiomorfolinderivater - Google Patents

Nye tiazin- eller tiomorfolinderivater

Info

Publication number
NO950387L
NO950387L NO950387A NO950387A NO950387L NO 950387 L NO950387 L NO 950387L NO 950387 A NO950387 A NO 950387A NO 950387 A NO950387 A NO 950387A NO 950387 L NO950387 L NO 950387L
Authority
NO
Norway
Prior art keywords
hydroxy
amld
loweralkyl
ester
protected
Prior art date
Application number
NO950387A
Other languages
English (en)
Other versions
NO950387D0 (no
Inventor
Yoichi Kawashima
Atsutoshi Ota
Hiroyuki Mibu
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of NO950387D0 publication Critical patent/NO950387D0/no
Publication of NO950387L publication Critical patent/NO950387L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/12—1,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

Det blir beskrevet forbindelser med formel (I) som er nyttige for behandling av katarakter, og syntetiske mellomprodukter med formelen (II), A-R< (D (II) hvor RI er hydroksy som kan være beskyttet av en hydroksybe- skyttende gruppe; R2 er laverealkyl; R3 er hydrogen, laverealkyl, hydroksy, som kan være beskyttet av en hydroksybeskyttende gruppe, eller laverealkyl, og nevnte laverealkyl kan være substituert med hydroksy, som kan være beskyttet av en hydroksybeskyttende gruppe, amlno eller lavereal- kylamlno; R4 er karboksy som kan bil omdannet til ester eller amld; tetrazolyl; fosfono som kan bil omdannet til ester eller amld; eller sulfonyl som kan bli omdannet til ester eller amld; R5 er cyano eller laverealkoksy; A er alkylen; B er C-0, C-S eller CH2, og ^^ er enkelblndlng eller dobbelblndlng.
NO950387A 1994-02-04 1995-02-02 Nye tiazin- eller tiomorfolinderivater NO950387L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1297994 1994-02-04

Publications (2)

Publication Number Publication Date
NO950387D0 NO950387D0 (no) 1995-02-02
NO950387L true NO950387L (no) 1995-08-07

Family

ID=11820343

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950387A NO950387L (no) 1994-02-04 1995-02-02 Nye tiazin- eller tiomorfolinderivater

Country Status (9)

Country Link
US (1) US5556841A (no)
EP (1) EP0666261B1 (no)
KR (1) KR950032158A (no)
CN (1) CN1112924A (no)
AT (1) ATE152714T1 (no)
CA (1) CA2141780A1 (no)
DE (1) DE69500274T2 (no)
FI (1) FI950493A7 (no)
NO (1) NO950387L (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0779282A1 (en) * 1995-12-14 1997-06-18 Eli Lilly And Company Thiomorpholinone compounds for treating multiple sclerosis
US5981523A (en) * 1996-02-05 1999-11-09 Eli Lilly And Company Compounds and methods for treating multiple sclerosis
CN1103592C (zh) * 1996-05-22 2003-03-26 永光制药有限公司 含有2－(苯基亚氨基)－3－苯基－1,3－全氢噻嗪的药物组合物及其应用和制备方法
UA56185C2 (uk) 1996-09-30 2003-05-15 Пфайзер Інк. Аралкіл- та аралкіліденгетероциклічні лактами та іміди, фармацевтична композиція та спосіб лікування
US6423708B1 (en) 1996-09-30 2002-07-23 Pfizer Inc Aralkyl and aralkylidene heterocyclic lactams and imides
WO2001007419A1 (en) * 1999-07-26 2001-02-01 Santen Pharmaceutical Co., Ltd. Novel thiazine or pyrazine derivatives
JP4981673B2 (ja) * 2005-09-13 2012-07-25 エーザイ・アール・アンド・ディー・マネジメント株式会社 安定性が改善されたクロロメチルフォスフェイト誘導体を含む組成物およびその製造方法
CN103619854A (zh) * 2011-04-29 2014-03-05 西奈山伊坎医学院 激酶抑制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50126676A (no) * 1974-03-22 1975-10-04
JPS50126677A (no) * 1974-03-22 1975-10-04
IE58312B1 (en) * 1984-05-18 1993-09-08 Union Pharma Scient Appl Heterocyclic derivatives, processes for their preparation and drugs in which they are present, which are useful especially as aldose reductase inhibitors
JPH0730058B2 (ja) * 1988-05-14 1995-04-05 参天製薬株式会社 ３−オキソ−１，４−ベンゾチアジン誘導体
IE914455A1 (en) * 1990-12-27 1992-07-01 Green Cross Corp 1,4-benzothiazine-2-acetic acid derivatives, processes for production thereof
JPH0672876A (ja) * 1992-03-26 1994-03-15 Tsumura & Co 末梢血管抵抗改善による血圧降下剤
ATE197297T1 (de) * 1992-08-31 2000-11-15 Santen Pharmaceutical Co Ltd 3-oxo-1,4-benzothiazin-derivate

Also Published As

Publication number Publication date
FI950493L (fi) 1995-08-05
KR950032158A (ko) 1995-12-20
FI950493A0 (fi) 1995-02-03
CA2141780A1 (en) 1995-08-05
EP0666261B1 (en) 1997-05-07
DE69500274T2 (de) 1997-09-25
NO950387D0 (no) 1995-02-02
CN1112924A (zh) 1995-12-06
DE69500274D1 (de) 1997-06-12
US5556841A (en) 1996-09-17
ATE152714T1 (de) 1997-05-15
FI950493A7 (fi) 1995-08-05
EP0666261A1 (en) 1995-08-09

Similar Documents

Publication Publication Date Title
AU7077894A (en) Immunosuppressant and antiallergic compounds, e.g. n-(3-oxohexanoyl) homoserine lactone
TW360990B (en) Electroconversion cell
AU699008B2 (en) Aminothiazole derivative, medicament containing the same, and intermediate for preperation of said compound
AU7597596A (en) Inhibitors of protein isoprenyl transferases
DE69303032D1 (de) Als süsstoffe brauchbare verbindungen und hir herstellungsverfahren
TR200102957T2 (tr) Sitalopram hazırlanması için metod.
CY1105863T1 (el) Παραγωγα εποθιλονης και η συνθεση και η χρηση τους
HUT54149A (en) Process for producing new 3-brackets open 4-(1-substituted-4-piperazinyl)-butyl brackets closed-4-thiazolidinone derivatives and pharmaceutical compositions comprising such compounds
IS6257A (is) Frumuviðloðunartálmar
ATE200286T1 (de) Chinolincarbonsäure-derivate
NO984939L (no) Azetidinon-derivater for behandling av atherosklerose
ATE190052T1 (de) Thiazolidindione-derivate, ihre herstellung und verwendung
PT918776E (pt) Sintese total de acilfulvenos antitumorais
BG101402A (en) Apoliprotein-b synthesis inhibitors
NO950387L (no) Nye tiazin- eller tiomorfolinderivater
MX9600842A (es) Derivados de ciclos de amida.
NO960441L (no) Benzopyraner og farmasöytiske forbindelser inneholdende dem
NO904031D0 (no) Fremgangsmaate ved fremstilling av beta-karbonyl-karboksyamider av 1,3-tiazolidiner.
DE69813554D1 (de) Cyclische harnstoff- und lactamderivate von benzo(5,6)cycloheptapyridinen zur verwendung als farnesyl-protein-transferase-hemmer
IE790771L (en) 1,2-disubstituted pyrrolidine and piperidine compounds.
AP2001002314A0 (en) Substituted benzolactam compounds.
LV10944A (lv) N-(hidroksietil)butandiamida atvasinajumi ka renina inhibitori
YU200791A (sh) Trifluorometil 1-karba (1-detia) cefemi
DE69609202D1 (de) Stereoselektive herstellung von 2-substituierten succinatderivaten
NO944762L (no) Nye 3-okso-1,4-benzotiazinderivater